bf/NASDAQ:SGMO_icon.jpeg

COM:SANGAMO

Sangamo Therapeutics, Inc.

  • Stock

Last Close

1.95

21/11 21:00

Market Cap

82.75M

Beta: -

Volume Today

3.28M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
24.13M
-
45.87M
90.07%
39.54M
13.80%
19.39M
50.96%
36.57M
88.60%
84.45M
130.95%
102.43M
21.29%
118.19M
15.39%
110.70M
6.34%
111.30M
0.54%
176.23M
58.34%
cost of revenue
22.19M
-
gross profit
24.13M
-
45.87M
90.07%
39.54M
13.80%
19.39M
50.96%
36.57M
88.60%
84.45M
130.95%
102.43M
21.29%
118.19M
15.39%
110.70M
6.34%
111.30M
0.54%
154.04M
38.40%
selling and marketing expenses
-23.29M
-
general and administrative expenses
13.80M
-
15.68M
13.60%
19.20M
22.45%
26.33M
37.16%
27.20M
3.30%
46.74M
71.82%
61.69M
31.99%
67.10M
8.77%
63.22M
5.78%
62.68M
0.85%
61.17M
2.42%
selling general and administrative expenses
13.80M
-
15.68M
13.60%
19.20M
22.45%
26.33M
37.16%
27.20M
3.30%
46.74M
71.82%
61.69M
31.99%
67.10M
8.77%
63.22M
5.78%
62.68M
0.85%
37.88M
39.58%
research and development expenses
36.98M
-
56.74M
53.45%
67.20M
18.42%
65.62M
2.35%
65.73M
0.17%
114.87M
74.76%
145.92M
27.04%
180.65M
23.80%
230.82M
27.77%
249.90M
8.27%
230.46M
7.78%
other expenses
82K
-
364K
343.90%
431K
18.41%
887K
105.80%
155.01M
-
cost and expenses
50.78M
-
72.42M
42.62%
86.39M
19.30%
91.95M
6.43%
92.93M
1.07%
161.60M
73.90%
207.61M
28.47%
247.74M
19.33%
294.04M
18.69%
312.58M
6.31%
290.52M
7.06%
operating expenses
50.78M
-
72.42M
42.62%
86.39M
19.30%
91.95M
6.43%
92.93M
1.07%
161.60M
73.90%
207.61M
28.47%
247.74M
19.33%
294.04M
18.69%
312.58M
6.31%
268.33M
14.16%
interest expense
-9.43M
-
ebitda
-26.59M
-
-26.32M
1.00%
-46.86M
78.02%
-72.56M
54.86%
-56.36M
22.32%
-77.15M
36.89%
-105.18M
36.33%
-129.55M
23.17%
-183.34M
41.52%
-201.28M
9.79%
-92.10M
54.24%
operating income
-26.71M
-
-26.78M
0.28%
-46.86M
74.96%
-72.56M
54.86%
-56.36M
22.32%
-77.15M
36.89%
-105.18M
36.33%
-129.55M
23.17%
-183.34M
41.52%
-201.28M
9.79%
-114.29M
43.22%
depreciation and amortization
569K
-
549K
3.51%
988K
79.96%
997K
0.91%
1.50M
50.25%
2.36M
57.48%
9.61M
307.25%
13.37M
39.16%
17.64M
31.93%
20.56M
16.58%
22.19M
7.93%
total other income expenses net
-60K
-
-230K
283.33%
431K
287.39%
887K
105.80%
1.79M
102.14%
8.26M
360.74%
9.76M
18.16%
8.78M
10.10%
5.35M
39.08%
9.43M
76.43%
-148.61M
1,675.60%
income before tax
-26.62M
-
-26.42M
0.78%
-46.42M
75.74%
-71.67M
54.38%
-54.57M
23.86%
-68.89M
26.24%
-95.42M
38.51%
-120.78M
26.58%
-177.99M
47.37%
-191.85M
7.79%
-262.90M
37.04%
income tax expense
-591K
-
-683K
15.57%
-5.72M
737.77%
-14K
99.76%
-1.50M
10,600%
8.26M
651.47%
-19.60M
337.27%
345K
101.76%
306K
11.30%
429K
40.20%
-5.07M
1,282.28%
net income
-26.62M
-
-26.42M
0.78%
-40.70M
54.08%
-71.66M
76.05%
-54.57M
23.85%
-68.33M
25.23%
-75.82M
10.95%
-121.12M
59.75%
-178.30M
47.20%
-192.28M
7.84%
-257.83M
34.09%
weighted average shs out
55.97M
-
67.02M
19.74%
69.76M
4.08%
70.55M
1.14%
78.08M
10.67%
96.94M
24.15%
112.11M
15.65%
134.45M
19.92%
144.57M
7.53%
154.34M
6.76%
174.44M
13.02%
weighted average shs out dil
55.97M
-
67.02M
19.74%
69.76M
4.08%
70.55M
1.14%
78.08M
10.67%
96.94M
24.15%
112.11M
15.65%
134.45M
19.92%
144.57M
7.53%
154.34M
6.76%
174.44M
13.02%
eps
-0.48
-
-0.39
18.75%
-0.58
48.72%
-1.02
75.86%
-0.70
31.37%
-0.70
0%
-0.68
2.86%
-0.90
32.35%
-1.23
36.67%
-1.25
1.63%
-1.48
18.40%
epsdiluted
-0.48
-
-0.39
18.75%
-0.58
48.72%
-1.02
75.86%
-0.70
31.37%
-0.70
0%
-0.68
2.86%
-0.90
32.35%
-1.23
36.67%
-1.25
1.63%
-1.48
18.40%

All numbers in (except ratios and percentages)